Study Aims to Shake Up Status Quo for Heart Failure Diagnosis
When it comes to diagnosing heart disease, earlier is always better. But in America, roughly 20-30% of people with heart failure with preserved ejection fraction, or HFpEF, experience delays to diagnosis each year. Yulia Khodneva, M.D., Ph.D., Assistant Professor in the Division of Preventive Medicine, is using her K23 grant from the National Heart, Lung, and Blood Institute to better understand barriers to diagnosing HFpEF. She plans to survey primary care doctors and APPs to gather their input on a practical intervention to improve diagnosis and referral to heart specialists. Her study is currently recruiting primary care providers from both academic and community practice, with subsequent phases of design and implementation through 2028.
Willing to participate in the survey? Email Dr. Khodneva for details.
Read more
UAB CVI Relaunches Women's Health Program
Gretchen Wells, M.D., Ph.D., (Professor, CVD) leads the UAB Cardiovascular Institute's newly relaunched Women's Heart Health Program. Program experts collaborate with specialities across the institution to address distinct concerns and risks factors unique to women's heart health including coronary microvascular disease, heart failure, spontaneous coronary artery dissection and cardiovascular complication of pregnancy. Through this program, UAB will be one of two facilities in the state able to assess for coronary microvascular disease through coronary functional testing.
Read moreIM Residency Matches 42 Trainees
On Friday, March 15, the Tinsley Harrison Internal Medicine Residency Program celebrated Match Day by welcoming 42 residents and trainees. The program matched 38 Categorical and 4 Med-Peds trainees including 1 underrepresented in medicine trainee and 15 women from 23 medical schools. The new interns will join UAB this summer.
Read moreMartin Shines Bright as Spring 2024 DOM STAR
The Department of Medicine is delighted to celebrate Brittany Martin as the latest winner of the DOM STAR Award for Staff Excellence. Faculty, staff, and colleagues sent glowing nomination letters in support of this clinical research administrator in the Division of Infectious Diseases, highlighting her keen ability to manage international projects, exemplary work ethic, and unmatched kindness and leadership. Martin was also recently recognized by the UAB VIP Awards for her lasting impact on the fabric and culture of UAB. Congrats, Brittany, and thank you for your wonderful contributions to global health and medicine!
Read moreLong-acting, Injectable ART Offers Promising New Treatment for Individuals Living with HIV
In a clinical trial led by Aadia Rana, M.D., professor in the UAB Division of Infectious Diseases, findings show that long-acting, injectable antiretroviral therapy (ART) is more effective in suppressing HIV than daily oral regimens. Because of its substantial benefits and potential impact, an independent safety monitoring board recommended halting randomization and offering all participants long-acting injectable therapy. Rana hopes that this study will expand HIV treatment guidelines to reach those with a history of non-adherence.
Read more